The relationship between the variants in 5′ upstream core promoter A (- 6) G and A (- 20) C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang

Chinese Journal of Medical Genetics

Volumn 21, Issue 1, 2004, Pages 23-28

  Li, Nan Fang ^a   Zhou, Ling ^a   Wu, Wei Dong ^a   Shi, Yan ^a   Wang, Xin Ling ^a   Wang, Jun ^a   Li, Hong Jian ^b   Zhang, De Lian ^a   Zuhere, ^a   Ouyang, Wei Jin ^a   Bu, Ke Li ^a   Zhou, Ke Ming ^a   Cheng, Qiu Yan ^a   Guli, Nur ^a   Zhu, Deng Hao ^c  

^a Xinjiang People's Hospital   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c The People's Hosp of Fuhai County   (China)

Author keywords

5 upstream core promoter; Angiotensinogen gene; Essential hypertension; Genetic polymorphism; Kazakans

Indexed keywords

ANGIOTENSINOGEN;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CHINA; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA DETERMINATION; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

5' FLANKING REGION; ADULT; ALLELES; ANGIOTENSINOGEN; BASE SEQUENCE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHINA; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS);

EID: 10744231917     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen gene. Cell, 1992, 71: 169-180.
2. Liu TC, Hou SQ, Zhang L, et al. New single nucleotide polymorphism (SNP) loci of angiotensinogen gene in China Han. Basic Med Clin, 2002, 22': 219-227.
3. Sethi AA, Nordestgaard BG, Agerholm-Larsen B, et al. Angiotensinogen potymorphisms and elevated blood pressure in the general population: the Copenhagen City Heart Study. Hypertension, 2001, 37: 875-881.
4. Iso H, Harada S, Shimamoto T, et al. Angiotensinogen T174M and M235T variants, sodium intake and hypertension among non-drinking, lean Japanese man and women. J Hypertens, 2000, 18: 1197-1206.
5. Suwazono Y, Kobayashi E, Sakurada I, et al. Associations of the angiotensinogen gene (M235T, T174M) and angiotension I-converting enzyme gene (I/D) with blood pressure in Japanese workers. Blood Press, 1999, 8: 23-28.
6. Chiang FT, Hsu KL, Tseng CD, et al. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens, 1997, 15: 607-611.
7. Staessen JA, Kuznetsova T, Wang JG, et al. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens, 1999, 17: 9-17.
8. Fukamizu A, Takahashi S, Seo MS, et al. Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter. J Biol Chem, 1990, 265: 7576-7582.
9. Inoue I, Nakajima T, Williams CS, et al, A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest, 1997, 99: 1786-1797.
10. Ishigami T, Umemura S, Tamura K, et al. Essential hypertension and 5' upstream core promoter region of human angiotensinogen gene. Hypertension, 1997,30: 1325-1330.
11. Zhao YY, Zhou J, Narayanan CS, et al. Role of C/A polymorphism at - 20 on the expression of human angiotensinogen gene. Hypertension, 1999, 33: 108-115.
12. Jeunemaitre X, Inoue I, Williams C, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet, 1997, 60: 1448-1460.
13. Tiago AD, Samani NJ, Candy GP, et al. Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. Circulation, 2002, 106: 1483-1487.
14. Wu YK, Lu CQ, Gao RC, et al. Nation-wide hypertension screening in China during 1979-1980. Chin Med J, 1982, 95: 101-108.
15. Yanai K, Nibu Y, Murakami K, et al. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequence in human angiotensinogen gene. J Biol Chem, 1996, 271: 15981-15986.
16. Yanai K, Saito T, Hirota K, et al. Molecular variation of the human angiotensinogen core promoter element located between the TATA box and transcription initiation site affects its transcriptional activity. J Biol Chem, 1997, 272: 30558-30562.
17. Hunt SC, Cook NR, Oberman A, et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension, prevention, phase I. Hypertension, 1998, 32: 393-401.]
18. Yang C, Qiu CC, Lu SD, et al. Association analysis of variants in the core promoter region of angiotensinogen gene with essential hypertension in Tibetan population. Chin J Med Genet, 2000, 17: 149-152.
19. Dronmasterin, Zhuang LP, Cui CY, et al. Genetic basis of essential hypertension. Natl Med J China, 2002, 10; 82: 1009-1012.
20. Liu Y, Qin W, Hou S, et al. A-6G variant of the angiotensinogen gene and essential hypertension in Han, Tibetan, and Yi populations, Hypertens Res, 2001, 24: 159-163.
21. Wang JH, Lin CM, Wang LS, et al. Association between molecular variants of the angiotensinogen gene and hypertension in Amis tribes of eastern Taiwan. J Formos Med Assoc, 2002, 101: 183-188.
22. Hegele RA, Harris SB, Hanley AJ, et al. - 6A promoter variant of angiotensinogen and blood pressure variation in Canadian Oji-Cree. J Hum Genet, 1998, 43: 37-41.
23. Sato N, Katsuya T, Rakugi H, et al. Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese, Hypertension, 1997, 30: 321-325.
24. Morgan L, Broughton-Pipkin F, Kalsheker N, et al. DNA polymorphisms and linkage disequilibrium in the angiotensinogen gene. Hum Genet, 1996, 98: 194-198.
25. Hilgers KF, Delles C, Veelken R, et al. Angioten gene core promoter variants and non-modulating hypertension. Hypertension, 2001, 38: 1250-1254.